Aster Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.34K Buy
+46
New +$6.82K ﹤0.01% 817

Other funds holding PVLA

Aster Capital Management's PVLA Position: Q3 2026 in Review

Aster Capital Management opened a new position in Palvella Therapeutics (PVLA) in Q3 2026: 46 shares worth $6.34K. The stake represents ﹤0.01% of the portfolio and ranks #817 among its holdings.

199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • Aster Capital Management held 46 shares of Palvella Therapeutics worth $6.34K as of Q3 2026.
  • Palvella Therapeutics was a new Aster Capital Management position in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #817 holding.
  • 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.